Clinical Trials Browser

Phase EARLY_PHASE1 × Spironolactone × Clear all

NCT03068910 2025-08-05

CRM008

Phase EARLY_PHASE1 Recruiting

Polycystic Ovary Syndrome, Hyperandrogenism

NCT04723862 2025-08-05

CBS010

Phase EARLY_PHASE1 Recruiting

Polycystic Ovary Syndrome, Hyperandrogenism

NCT04075149 2023-10-27

CBS009

Phase EARLY_PHASE1 Unknown

Polycystic Ovary Syndrome, Hyperandrogenism

NCT02689843 2019-11-12

AntiPCO

Phase EARLY_PHASE1 Completed

Inflammation, Polycystic Ovary Syndrome